UNIGENE LABORATORIES INC Financing Cash Flow
UNIGENE LABORATORIES INC reported Financing Cash Flow of -$9.28 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2013-05-14
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was -$9.28K.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was -$9.04K, a 100.52% decline year-over-year.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $3.73M, a 2727.22% increase year-over-year.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was -$308.22K.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for fiscal 2012 was $3.40M, a 76.93% increase from fiscal 2011.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for fiscal 2011 was $1.92M, a 80.11% decline from fiscal 2010.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for fiscal 2010 was $9.65M, a 111.17% increase from fiscal 2009.
- UNIGENE LABORATORIES INC net cash provided by (used in) financing activities for fiscal 2009 was $4.57M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$9.28K 10-Q · filed 2013-05-14 | -$18.32K derived: sum of 2 quarters · filed 2013-05-14 | $3.71M derived: sum of 3 quarters · filed 2013-05-14 | $3.40M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | -$9.04K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.72M derived: sum of 2 quarters · filed 2013-03-15 | $3.41M derived: sum of 3 quarters · filed 2013-03-15 | $3.40M 10-K · filed 2013-03-15 |
| 2012-09-30 | $3.73M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | $3.42M derived: sum of 2 quarters · filed 2013-01-31 | $3.41M 10-Q · filed 2013-01-31 | $5.14M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | -$308.22K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31 | -$322.26K 10-Q/A · filed 2013-01-31 | $1.41M derived: sum of 3 quarters · filed 2013-05-14 | $1.54M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | -$14.04K 10-Q · filed 2013-05-14 | $1.72M derived: sum of 2 quarters · filed 2013-05-14 | $1.85M derived: sum of 3 quarters · filed 2013-05-14 | |
| 2011-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.87M derived: sum of 2 quarters · filed 2013-03-15 | $1.92M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $131.90K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | $185.42K 10-Q · filed 2013-01-31 | ||
| 2011-06-30 | $53.52K 10-Q/A · filed 2013-01-31 | |||
| 2010-12-31 | $70.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $71.91K derived: sum of 2 quarters · filed 2013-03-15 | $9.65M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $1.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $9.58M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $9.58M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $4.57M 10-K/A · filed 2013-01-31 |